Difference between revisions of "Drug index"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (link to antimicrobial guidelines)
Line 1: Line 1:
 
*[[Antidepressants and other psychiatric medications in cancer care]]
 
*[[Antidepressants and other psychiatric medications in cancer care]]
 
*[[Antiemesis|Antiemetic support]]
 
*[[Antiemesis|Antiemetic support]]
 +
*[http://jco.ascopubs.org/content/early/2013/01/08/JCO.2012.45.8661.full.pdf+html Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline (2013)]
 
*[http://jco.ascopubs.org/content/30/13/1553.long Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [http://jco.ascopubs.org/content/30/13/1553.long link to original article] [http://www.ncbi.nlm.nih.gov/pubmed/22473167 PubMed]</ref>
 
*[http://jco.ascopubs.org/content/30/13/1553.long Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [http://jco.ascopubs.org/content/30/13/1553.long link to original article] [http://www.ncbi.nlm.nih.gov/pubmed/22473167 PubMed]</ref>
 
*[http://www.asco.org/ASCOv2/Practice+%26+Guidelines/Quality+Care/Quality+Measurement+%26+Improvement/ASCO-ONS+Standards+for+Safe+Chemotherapy+Administration+%5B2011%5D ASCO-ONS Standards for Safe Chemotherapy Administration (2011)]
 
*[http://www.asco.org/ASCOv2/Practice+%26+Guidelines/Quality+Care/Quality+Measurement+%26+Improvement/ASCO-ONS+Standards+for+Safe+Chemotherapy+Administration+%5B2011%5D ASCO-ONS Standards for Safe Chemotherapy Administration (2011)]
Line 238: Line 239:
 
*[[Pralatrexate (Folotyn)]]
 
*[[Pralatrexate (Folotyn)]]
 
*[[Prednisone (Sterapred)]]
 
*[[Prednisone (Sterapred)]]
 +
*[[Prednisolone (Millipred)]]
 
*[[Procarbazine (Matulane)]]
 
*[[Procarbazine (Matulane)]]
 
*[[Protamine sulfate]]
 
*[[Protamine sulfate]]

Revision as of 23:26, 15 January 2013

A

B

C

D

E

F

G

H

I

L

M

N

O

P

R

S

T

U

V

W

Z

References

  1. ↑ Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed
  2. ↑ Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article
Retrieved from "https://hemonc.org/w/index.php?title=Drug_index&oldid=2356"